Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers163
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer113
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia85
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies72
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma60
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead55
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes53
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect51
Whole Abdominal Radiotherapy in Bone and Soft Tissue Sarcomas: Indications, Techniques, Clinical Outcomes, and Future Directions48
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer47
An Update on Temporal Bone Paragangliomas42
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?42
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers40
Management of Fatigue in Patients with Advanced Cancer40
Approach to Localized Squamous Cell Cancer of the Esophagus39
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma34
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors34
Small Cell Lung Cancer—An Update on Chemotherapy Resistance33
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer32
The Role of Nursing in the Delivery of Cardio-Oncology32
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer32
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities31
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements29
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations29
Regorafenib for the Treatment of Sarcoma28
Advances in Targeted Therapy for Metastatic Prostate Cancer28
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?27
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia27
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs27
Gastric Cancer with Sarcopenia: an Area Worth Focusing On26
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?25
Recognition and Management of the Long-term Effects of Cranial Radiation25
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas25
Research Progress on Ferroptosis in Multiple Myeloma24
Endocrinologic Toxicities of Cancer Therapy: Evolving Challenges and Multidisciplinary Approaches24
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment24
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond23
Response Evaluation of Neoadjuvant Therapies in Sarcoma23
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer22
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis22
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy21
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)21
Dyadic Interventions for LGBTQ+ Individuals Facing Cancer: A Narrative Review21
Transforming a Roadblock into a Roadmap: Evolving HFSR Management From Adverse Event to Efficacy Biomarker21
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors21
Contemporary Review of Adenocarcinoma of the Cervix20
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer20
Treatment Options for Brain Metastases20
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities20
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract20
Novel Estrogen Receptor-Targeted Agents for Breast Cancer20
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers20
Understanding, Recognizing, and Managing Cancer-Related Fatigue Associated with Breast Cancer19
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer19
Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation19
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?19
Perioperative Immune Checkpoint Inhibitors for the Treatment of Locally Advanced Gastric and Gastroesophageal Junction Cancer: Current Status and Future Prospects19
Updates in Management of Malignant Pleural Mesothelioma19
Progress in the Treatment of Small Intestine Cancer19
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer19
How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia18
Updates in Breast Cancer Screening and Diagnosis18
The Role of Induction Therapy for Sinonasal Cancers17
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma17
Advances in PSMA-Targeted Radionuclide Therapeutics17
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations17
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives17
Myxoid Liposarcomas: Systemic Treatment Options17
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease17
Correction to: Cardiotoxicity of Systemic Melanoma Treatments16
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer16
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective16
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus16
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?16
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer16
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management15
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review15
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer15
The Role of SIRT1 in Leukemia15
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy14
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies14
Management of Functional Pancreatic Neuroendocrine Neoplasms14
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?14
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors14
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?14
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management14
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches14
Therapeutic Management of Malignant Wounds: An Update14
Systemic Therapy for Salivary Gland Cancers: A Review of Targeted and Chemotherapeutic Approaches13
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming13
Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic13
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance13
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation13
Dermatofibrosarcoma Protuberans (DFSP): Diagnostics and Molecular Pathology13
Advancements in Melanoma Therapies: From Surgery to Immunotherapy13
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions13
HER2-Positive Metastatic Colorectal Cancer13
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?13
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?12
Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice12
Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma12
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer12
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer12
Diagnosis and Treatment of Myxoid Liposarcoma12
Targeted Therapy in Early Stage Non-small Cell Lung Cancer12
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes12
Impact of PSMA PET on Prostate Cancer Management12
Nanomedicine-Based Treatments for Rare and Aggressive Ocular Cancers: Advances in Drug Delivery12
The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy12
Community Palliative Care: What are the Best Models?12
0.85526704788208